BOTASXBotanix Pharmaceuticals Ltd

BOT price activity

Last Price

Change (24hr)

AUD (%)

Volume

Volume (4w avg)

Previous Close

N/A

Last Trade

BOT price performance

-12,5%

-84,44%

YTD

-85,52%

BOT price fundamentals

N/A

Shares Issued

N/A

Earnings Per Share (EPS)

N/A

Dividends Per Share (DPS)

N/A

P/E Ratio

Price market cap

Market cap

N/A

AU-ASX rank

N/A

Sector Rank

N/A

BOT details

View company profile

View company website

View AU-ASX Official Page

Dividendos de BOT

Ver mais

quote.marketSignals

Mais formas de descobrir

Ver notícias de Australia Descubra sinais de ASX Ver todas as ações de ASX Ver todos os ETFs de ASX

Botanix Pharmaceuticals Ltd (AU-ASX: BOT)

Botanix Pharmaceuticals Limited operates as a commercial dermatology company in Australia and the United States. The company's lead product is Sofdra (sofpironium) topical gel, a prescription anticholinergic medicine used on the skin to treat underarm sweating in adults and children 9 years of age and older. Its product pipeline includes BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers; BTX 1801 for treating staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 for the treatment of papulopustular rosacea; and BTX 1204A for treating atopic dermatitis. The company was incorporated in 1984 and is based in Melbourne, Australia.

Price: A$0.02

Sector: Healthcare — Biotechnology